Fresenius Purchase of NxStage Delayed Until August by FTC
The government shutdown delayed FTC approval of a Fresenius acquisition of NxStage Medical, Inc. The transaction is now expected to close in August 2019.
Read the full article » | Posted 02-14-2019
Related Articles
- Fresenius Medical Care named Shervin Korangy as CEO Posted 10-22-2026
- Aligning Clinical Excellence with Health System Goals Through PD in Value-Based Models Posted 10-22-2026
- Update on National Institutes of Health websites Posted 10-22-2026
- What to Know About the American Society of Nephrology Kidney Week Posted 10-22-2026